Gene · 6346
Papers2,807
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,807
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Histone modifications in drug-resistant cancers: From a cancer stem cell and immune evasion perspective. | Exp Mol Med | 2023 | 37394580 | PubTator, text mining | PubMed |
| Differentiated expressed miRNAs in splenic monocyte induced by burn injury in mice. | Int Wound J | 2023 | 37386845 | PubTator, text mining | PubMed |
| Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy. | Cancer Res Commun | 2023 | 37377898 | PubTator, text mining | PubMed |
| High Expression Levels of miR-21-5p in Younger Hospitalized COVID-19 Patients Are Associated with Mortality and Critical Disease. | Int J Mol Sci | 2023 | 37373259 | PubTator, text mining | PubMed |
| An In Vitro Alveolar Model Allows for the Rapid Assessment of Particles for Respiratory Sensitization Potential. | Int J Mol Sci | 2023 | 37373252 | PubTator, text mining | PubMed |
| Revisiting the neuroinflammation hypothesis in Alzheimer's disease: a focus on the druggability of current targets. | Front Pharmacol | 2023 | 37361208 | PubTator, text mining | PubMed |
| The biological function of tumor-derived extracellular vesicles on metabolism. | Cell Commun Signal | 2023 | 37349803 | PubTator, text mining | PubMed |
| Dysregulated peripheral proteome reveals NASH-specific signatures identifying patient subgroups with distinct liver biology. | Front Immunol | 2023 | 37342340 | PubTator, text mining | PubMed |
| Investigation of KIR/HLA relationship and other clinical variables after T-cell-replete haploidentical bone marrow transplantation in patients with acute myeloid leukemia (AML). | BMC Immunol | 2023 | 37340345 | PubTator, text mining | PubMed |
| Keratinocytes use FPR2 to detect Staphylococcus aureus and initiate antimicrobial skin defense. | Front Immunol | 2023 | 37325619 | PubTator, text mining | PubMed |
| Low Baseline CXCL9 Predicts Early Progressive Disease in Unresectable HCC with Atezolizumab Plus Bevacizumab Treatment. | Liver Cancer | 2023 | 37325489 | PubTator, text mining | PubMed |
| Low body mass index is associated with diminished plasma cytokines and chemokines in both active and latent tuberculosis. | Front Nutr | 2023 | 37324745 | PubTator, text mining | PubMed |
| Degranulation of Mast Cells as a Target for Drug Development. | Cells | 2023 | 37296626 | PubTator, text mining | PubMed |
| Blood and CSF chemokines in Alzheimer's disease and mild cognitive impairment: a systematic review and meta-analysis. | Alzheimers Res Ther | 2023 | 37291639 | PubTator, text mining | PubMed |
| Mesenchymal stromal cells and alpha-1 antitrypsin have a strong synergy in modulating inflammation and its resolution. | Theranostics | 2023 | 37284443 | PubTator, text mining | PubMed |
| Modulation of T cell function and survival by the tumor microenvironment. | Front Cell Dev Biol | 2023 | 37274739 | PubTator, text mining | PubMed |
| A pan-cancer analysis of the role of USP5 in human cancers. | Sci Rep | 2023 | 37268697 | PubTator, text mining | PubMed |
| LXR Signaling-Mediated Cholesterol Metabolism Reprogramming Regulates Cancer Cell Metastasis. | Cancer Res | 2023 | 37264829 | PubTator, text mining | PubMed |
| Antioxidant capacity and cytotoxic effect of an optimized extract of isabella grape (Vitis labrusca) on breast cancer cells. | Heliyon | 2023 | 37260897 | PubTator, text mining | PubMed |
| Combined analysis of single-cell and bulk RNA sequencing reveals the expression patterns of circadian rhythm disruption in the immune microenvironment of Alzheimer's disease. | Front Immunol | 2023 | 37251379 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6346/papers?page=16